Glenmede Trust’s Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 AAC.WS Stock Holding History

Glenmede Trust’s Portfolio AAC.WS Stock Details AAC.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-33,810	Closed	-$7K	–	1366
2022 Q2	$7K	Sell	33,810 -262	-0.8%	-$81	﹤0.01%	1264
2022 Q1	$14K	Buy	34,072 +416	+1%	+$233	﹤0.01%	1283
2021 Q4	$29K	Buy	+33,656	New	+$35.3K	﹤0.01%	1263

Other funds holding AAC.WS

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

AGC

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Glenmede Trust's AAC.WS Position: Q3 2022 in Review

Glenmede Trust sold out of Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (AAC.WS) in Q3 2022, closing a stake of 33,810 shares — an estimated $7K sold.

Glenmede Trust first reported a position in AAC.WS in Q4 2021 and held it in 3 quarters. The position peaked at $29K in Q4 2021. 79 funds tracked by Wall St. Rank hold AAC.WS as of Q3 2022.

Glenmede Trust reported no remaining Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
Glenmede Trust sold 33,810 Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $7K.
Glenmede Trust first reported a position in Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 3 quarters.
Glenmede Trust's Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $29K in Q4 2021.
79 funds tracked by Wall St. Rank held Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Glenmede Trust's 13F filing for Q3 2022, filed 16 Nov 2022.